1. Ileocaecal Disease : Resect or Medicate?
2. Dysplasia in IBD- endoscopic resection or colectomy?

Key Note Address:
Liver disorders in Inflammatory bowel Disease: NASH & Beyond.
Vascular complications of IBD: An overlooked problem.

1. Exit strategy from maintenance therapy in IBD : When, why & if to stop 5ASA, AZA, biologics?
2. Persistent symptoms in IBD: beyond active disease!
3. Audience interaction

1. Crohn’s Disease – post surgery – what next?
2. Recurrent Pouchitis – what next?

A 22 year old medical student with perianal fistula: A panel discussion on key Issues : 1. Timing of seton placement
2. Choice of antibiotic
3. Selecting the right biologic

1. Anti-TNFs and anti-integrins: Journey so far
2. JAK inhibition: tofacitinib and beyond
3. Ustekinumab: will it be the game changer?
4. Positioning biologics and small molecules: the current perspective
5. Audience Interaction
6. Launch of IBD-ENC Biologics Registry